{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:43:15Z","timestamp":1793299395813,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.neurobiolaging.2021.09.019","type":"journal-article","created":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T13:50:38Z","timestamp":1633009838000},"page":"125-134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Abnormal tau in amyloid PET negative individuals"],"prefix":"10.1016","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1135-3392","authenticated-orcid":false,"given":"Bora","family":"Yoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tengfei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5311-6758","authenticated-orcid":false,"given":"Karine","family":"Provost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6740-198X","authenticated-orcid":false,"given":"Deniz","family":"Korman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4681-8137","authenticated-orcid":false,"given":"Tyler J.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Landau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4458-113X","authenticated-orcid":false,"given":"William J","family":"Jagust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2021.09.019_bib0001","doi-asserted-by":"crossref","first-page":"e49132","DOI":"10.7554\/eLife.49132","article-title":"Cortical tau deposition follows patterns of entorhinal functional connectivity in aging","volume":"8","author":"Adams","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.neurobiolaging.2021.09.019_bib0002","doi-asserted-by":"crossref","first-page":"e1635","DOI":"10.1212\/WNL.0000000000008361","article-title":"Applying the ATN scheme in a memory clinic population","volume":"93","author":"Altomare","year":"2019","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.09.019_bib0003","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jalz.2018.07.215","article-title":"Neuropathologic, genetic, and longitudinal cognitive profiles in primary age-related tauopathy (PART) and Alzheimer's disease","volume":"15","author":"Bell","year":"2019","journal-title":"Alzheimers Dement"},{"issue":"16","key":"10.1016\/j.neurobiolaging.2021.09.019_bib0004","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1212\/WNL.0000000000004521","article-title":"Comparison of symptomatic and asymptomatic persons with primary age-related tauopathy","volume":"89","author":"Besser","year":"2017","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.neurobiolaging.2021.09.019_bib0005","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1093\/brain\/awy150","article-title":"Effects of amyloid pathology and neurodegeneration on cognitive change in cognitively normal adults","volume":"141","author":"Bilgel","year":"2018","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.09.019_bib0006","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","article-title":"Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry","volume":"112","author":"Braak","year":"2006","journal-title":"Acta Neuropathol"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.09.019_bib0007","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.09.019_bib0008","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/0197-4580(95)00021-6","article-title":"Staging of Alzheimer's disease-related neurofibrillary changes","volume":"16","author":"Braak","year":"1995","journal-title":"Neurobiol Aging"},{"issue":"10","key":"10.1016\/j.neurobiolaging.2021.09.019_bib0009","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S1474-4422(16)30125-9","article-title":"Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study","volume":"15","author":"Burnham","year":"2016","journal-title":"Lancet Neurol"},{"issue":"5","key":"10.1016\/j.neurobiolaging.2021.09.019_bib0010","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1212\/WNL.0000000000001209","article-title":"Mild cognitive impairment with suspected nonamyloid pathology (SNAP): Prediction of progression","volume":"84","author":"Caroli","year":"2015","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.09.019_bib0011","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/ana.24711","article-title":"In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum","volume":"80","author":"Cho","year":"2016","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.09.019_bib0012","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3233\/JAD-170201","article-title":"Hippocampal and Clinical Trajectories of Mild Cognitive Impairment with Suspected Non-Alzheimer's Disease Pathology","volume":"58","author":"Chung","year":"2017","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.09.019_bib0013","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s11682-012-9186-z","article-title":"Development and assessment of a composite score for memory in the Alzheimer's Disease Neuroimaging Initiative (ADNI)","volume":"6","author":"Crane","year":"2012","journal-title":"Brain Imaging Behav"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2021.09.019_bib0014","doi-asserted-by":"crossref","first-page":"53","DOI":"10.29245\/2572.942X\/2016\/6.1059","article-title":"Primary age-related tauopathy and the amyloid cascade hypothesis: the exception that proves the rule?","volume":"1","author":"Crary","year":"2016","journal-title":"J Neurol Neuromedicine"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2021.09.019_bib0015","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00401-014-1349-0","article-title":"Primary age-related tauopathy (PART): a common pathology associated with human aging","volume":"128","author":"Crary","year":"2014","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.09.019_bib0016","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00259-019-04536-9","article-title":"The A\/T\/N model applied through imaging biomarkers in a memory clinic","volume":"47","author":"Dodich","year":"2020","journal-title":"Eur J Nuclear Med Mol Imaging"},{"issue":"8","key":"10.1016\/j.neurobiolaging.2021.09.019_bib0017","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jamaneurol.2014.803","article-title":"The Preclinical Alzheimer Cognitive Composite: Measuring Amyloid-Related Decline","volume":"71","author":"Donohue","year":"2014","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.09.019_bib0018","first-page":"e12031","article-title":"Evaluation of the ATN model in a longitudinal memory clinic sample with different underlying disorders","volume":"13","author":"Eckerstr\u00f6m","year":"2021","journal-title":"Assess Dis Monit"},{"key":"10.1016\/j.neurobiolaging.2021.09.019_bib0019","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1001\/jamaneurol.2020.0528","article-title":"Positron emission tomography imaging with [18F]flortaucipir and postmortem assessment of Alzheimer disease neuropathologic changes","volume":"77","author":"Fleisher","year":"2020","journal-title":"JAMA Neurol"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.09.019_bib0020","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/ana.24186","article-title":"Cerebrospinal fluid beta-amyloid and phospho-tau biomarker interactions affecting brain structure in preclinical Alzheimer disease","volume":"76","author":"Fortea","year":"2014","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.09.019_bib0021","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s11682-012-9176-1","article-title":"A composite score for executive functioning, validated in Alzheimer's Disease Neuroimaging Initiative (ADNI) participants with baseline mild cognitive impairment","volume":"6","author":"Gibbons","year":"2012","journal-title":"Brain Imaging Behav"},{"issue":"8","key":"10.1016\/j.neurobiolaging.2021.09.019_bib0022","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.biopsych.2020.06.029","article-title":"Longitudinal cognitive and biomarker measurements support a unidirectional pathway in alzheimer\u2019s disease pathophysiology","volume":"89","author":"Guo","year":"2020","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2021.09.019_bib0023","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1001\/jamaneurol.2019.1424","article-title":"Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study","volume":"76","author":"Hanseeuw","year":"2019","journal-title":"JAMA Neurol"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.09.019_bib0024","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"5","key":"10.1016\/j.neurobiolaging.2021.09.019_bib0025","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","article-title":"A\/T\/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers","volume":"87","author":"Jack","year":"2016","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.09.019_bib0026","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nrneurol.2015.251","article-title":"Suspected non-Alzheimer disease pathophysiology\u2013concept and controversy","volume":"12","author":"Jack","year":"2016","journal-title":"Nat Rev Neurol"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2021.09.019_bib0027","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/ana.22628","article-title":"An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease","volume":"71","author":"Jack","year":"2012","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2021.09.019_bib0028","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/ana.22628","article-title":"An operational approach to National Institute on Aging\u2013Alzheimer's Association criteria for preclinical Alzheimer disease","volume":"71","author":"Jack","year":"2012","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.neurobiolaging.2021.09.019_bib0029","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/brain\/awy059","article-title":"Longitudinal tau PET in ageing and Alzheimer's disease","volume":"141","author":"Jack","year":"2018","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2021.09.019_bib0030","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S1474-4422(17)30077-7","article-title":"Age-specific and sex-specific prevalence of cerebral beta-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50-95 years: a cross-sectional study","volume":"16","author":"Jack","year":"2017","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.09.019_bib0031","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jalz.2016.08.005","article-title":"Defining imaging biomarker cut points for brain aging and Alzheimer's disease","volume":"13","author":"Jack","year":"2017","journal-title":"Alzheimers Dement"},{"issue":"7","key":"10.1016\/j.neurobiolaging.2021.09.019_bib0032","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jalz.2015.05.001","article-title":"The Alzheimer's Disease Neuroimaging Initiative 2 PET Core: 2015","volume":"11","author":"Jagust","year":"2015","journal-title":"Alzheimer's Dementia"},{"issue":"5","key":"10.1016\/j.neurobiolaging.2021.09.019_bib0033","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00401-015-1407-2","article-title":"PART, a distinct tauopathy, different from classical sporadic Alzheimer disease","volume":"129","author":"Jellinger","year":"2015","journal-title":"Acta Neuropathol"},{"issue":"5","key":"10.1016\/j.neurobiolaging.2021.09.019_bib0034","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00401-017-1681-2","article-title":"Tau aggregation influences cognition and hippocampal atrophy in the absence of beta-amyloid: a clinico-imaging-pathological study of primary age-related tauopathy (PART)","volume":"133","author":"Josephs","year":"2017","journal-title":"Acta Neuropathol"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.09.019_bib0035","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4132\/jptm.2019.03.14","article-title":"Primary Age-Related Tauopathy: An Elderly Brain Pathology Frequently Encountered during Autopsy","volume":"53","author":"Kim","year":"2019","journal-title":"J Pathol Transl Med"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.09.019_bib0036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2014.07.003","article-title":"The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET","volume":"11","author":"Klunk","year":"2015","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neurobiolaging.2021.09.019_bib0037","unstructured":"Landau, S., Jagust, W., 2015. Florbetapir Processing Methods. http:\/\/adni.loni.usc.edu\/"},{"key":"10.1016\/j.neurobiolaging.2021.09.019_bib0038","unstructured":"Landau, S., Jagust, W., 2016. Flortaucipir (AV-1451) Processing Methods. http:\/\/adni.loni.usc.edu\/."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.09.019_bib0039","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2967\/jnumed.112.109009","article-title":"Amyloid-beta imaging with Pittsburgh compound B and florbetapir: comparing radiotracers and quantification methods","volume":"54","author":"Landau","year":"2013","journal-title":"J Nucl Med"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.09.019_bib0040","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jalz.2019.09.079","article-title":"Tau-positron emission tomography correlates with neuropathology findings","volume":"16","author":"Lowe","year":"2020","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.09.019_bib0041","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/brain\/awx320","article-title":"Widespread brain tau and its association with ageing, Braak stage and Alzheimer's dementia","volume":"141","author":"Lowe","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2021.09.019_bib0042","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.neuroimage.2017.05.058","article-title":"Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease","volume":"157","author":"Maass","year":"2017","journal-title":"Neuroimage"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.09.019_bib0043","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1523\/JNEUROSCI.2028-17.2017","article-title":"Entorhinal Tau Pathology, Episodic Memory Decline, and Neurodegeneration in Aging","volume":"38","author":"Maass","year":"2018","journal-title":"J Neurosci"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.09.019_bib0044","first-page":"448","article-title":"The Alzheimer's disease assessment scale: an instrument for assessing treatment efficacy","volume":"19","author":"Mohs","year":"1983","journal-title":"Psychopharmacol Bull"},{"issue":"10","key":"10.1016\/j.neurobiolaging.2021.09.019_bib0045","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1001\/jamaneurol.2016.2237","article-title":"Heterogeneity in Suspected Non\u2013Alzheimer Disease Pathophysiology Among Clinically Normal Older Individuals","volume":"73","author":"Mormino","year":"2016","journal-title":"JAMA Neurol"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2021.09.019_bib0046","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1093\/brain\/awz099","volume":"142","author":"Nelson","year":"2019","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2021.09.019_bib0047","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jalz.2016.11.005","article-title":"Synergistic interaction between amyloid and tau predicts the progression to dementia","volume":"13","author":"Pascoal","year":"2017","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.09.019_bib0048","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s40478-019-0842-z","article-title":"Magnetic resonance imaging brain atrophy assessment in primary age-related tauopathy (PART)","volume":"7","author":"Quintas-Neves","year":"2019","journal-title":"Acta Neuropathol Commun"},{"issue":"5","key":"10.1016\/j.neurobiolaging.2021.09.019_bib0049","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/brain\/aww023","article-title":"Regional profiles of the candidate tau PET ligand 18 F-AV-1451 recapitulate key features of Braak histopathological stages","volume":"139","author":"Schwarz","year":"2016","journal-title":"Brain"},{"issue":"14","key":"10.1016\/j.neurobiolaging.2021.09.019_bib0050","doi-asserted-by":"crossref","first-page":"e1567","DOI":"10.1212\/WNL.0000000000007248","article-title":"ATN profiles among cognitively normal individuals and longitudinal cognitive outcomes","volume":"92","author":"Soldan","year":"2019","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.09.019_bib0051","first-page":"e12133","article-title":"Evaluation of a visual interpretation method for tau-PET with 18F-flortaucipir","volume":"12","author":"Sonni","year":"2021","journal-title":"Assess Dis Monitoring"},{"key":"10.1016\/j.neurobiolaging.2021.09.019_bib0052","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/s41374-019-0186-0","article-title":"Clinical diagnoses among individuals with primary age-related tauopathy versus Alzheimer's neuropathology","volume":"99","author":"Teylan","year":"2019","journal-title":"Lab Invest"},{"key":"10.1016\/j.neurobiolaging.2021.09.019_bib0053","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/brain\/awz403","article-title":"Cognitive trajectory in mild cognitive impairment due to primary age-related tauopathy","volume":"143","author":"Teylan","year":"2020","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.neurobiolaging.2021.09.019_bib0054","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.jalz.2019.06.4948","article-title":"MCI-to-normal reversion using neuropsychological criteria in the Alzheimer's Disease Neuroimaging Initiative","volume":"15","author":"Thomas","year":"2019","journal-title":"Alzheimers Dement"},{"issue":"11","key":"10.1016\/j.neurobiolaging.2021.09.019_bib0055","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/S1474-4422(19)30283-2","article-title":"van der Flier, W.M., 2019. Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study","volume":"18","author":"van Maurik","year":"2021","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.09.019_bib0056","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1046\/j.1440-1789.2003.00522.x","article-title":"Senile dementia of the neurofibrillary tangle type (tangle-only dementia): neuropathological criteria and clinical guidelines for diagnosis","volume":"23","author":"Yamada","year":"2003","journal-title":"Neuropathology"},{"issue":"9","key":"10.1016\/j.neurobiolaging.2021.09.019_bib0057","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.jalz.2019.05.006","article-title":"Frequency and longitudinal clinical outcomes of Alzheimer's AT (N) biomarker profiles: A longitudinal study","volume":"15","author":"Yu","year":"2019","journal-title":"Alzheimer's Dementia"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.09.019_bib0058","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s12264-018-0300-0","article-title":"Phosphorylated TDP-43 Staging of Primary Age-Related Tauopathy","volume":"35","author":"Zhang","year":"2019","journal-title":"Neurosci Bull"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.09.019_bib0059","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1001\/jamaneurol.2017.3029","article-title":"Amyloid \u03b2 Deposition and Suspected Non-Alzheimer Pathophysiology and Cognitive Decline Patterns for 12 Years in Oldest Old Participants Without Dementia","volume":"75","author":"Zhao","year":"2018","journal-title":"JAMA Neurol"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458021003006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458021003006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:41:09Z","timestamp":1759318869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458021003006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":59,"alternative-id":["S0197458021003006"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2021.09.019","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Abnormal tau in amyloid PET negative individuals","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2021.09.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}